Loading
A phase 2 trial of fruquintinib, sintilimab and tucidinostat (chidamide) in colorectal cancer, run by Dai, Guanghai, now recruiting.
Safety and Efficacy of Fruquintinib Plus Chidamide and Sintilimab in the Third and Later Line Treatment of MSS/pMMR Metastatic Colorectal Cancer is a phase 2, interventional study registered as NCT06685276 by Dai, Guanghai, with a registry enrolment figure of 46 participants, started 2024-08-16 and due to reach its primary completion in 2025-12. Interventions recorded: Fruquintinib; Sintilimab; Chidamide. Conditions listed: Colorectal Cancer Metastatic. Primary outcome: Progress-free Survival(PFS). Colorectal eligibility wording from the registry: "Patients with histologically confirmed unresectable locally advanced, recurrent, or metastatic colorectal adenocarcinoma;". Sites: China. No results are recorded here; the registry entry is the source.
Shares Tucidinostat (chidamide), Fruquintinib, Sintilimab, Anti-angiogenic therapy and the tag colorectal-deep-dive.
Shares Tucidinostat (chidamide), Fruquintinib, Anti-angiogenic therapy, Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Fruquintinib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Fruquintinib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Fruquintinib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Fruquintinib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Fruquintinib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Fruquintinib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.